3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ

Slides:



Advertisements
Similar presentations
HRCT of Common Lung Diseases W. Richard Webb MD. Common Lung Diseases: HRCT Infections (pneumonia, airways disease) Infections (pneumonia, airways disease)
Advertisements

High-Resolution Lung CT: Key Findings and What They Mean W
Academy Board Prep PCCM
These are actual cases to: –Stimulate your reading –Test your knowledge of the material Look for the sound icon (usually in the upper right hand corner.
F 1+7/12 yrs CC: cough and mild cyanosis Diffuse pulmonary opacity.
GENERAL MEDICINE CONFERENCE
Radiology of Connective Tissue Disease associated Interstitial Lung Disease John Murchison.
Clinical History Locke : 55 yo male past medical history of hypothyroidism presents with increasing dyspnea. Patient was treated with several.
COPD (Chronic Obstructive Pulmonary Disease)
INTERSTITIAL LUNG DISEASE
Idiopathic Pulmonary Fibrosis (IPF) How we could do better Dr. D. K. Pillai Wednesday, 13 th August 2014 Medical Update Group at UoM.
Hamlet’s Delight New Guidelines for IPF
IDIOPATHIC PULMONARY FIBROSIS
THE DIAGNOSIS OF IPF Steven A. Sahn, MD
IDIOPATHIC PULMONARY FIBROSIS
Management of Patients With Chronic Pulmonary Disease.
Habib GHEDIRA, MD, Prof. Medical Faculty of Tunis
NYU Medical Grand Rounds Clinical Vignette Lucy Doyle MD, PGY-2 March 24, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
NYU Medical Grand Rounds Clinical Vignette Pavan Bhatraju MD, PGY-II October 11, 2011 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
NYU Medical Grand Rounds Clinical Vignette Lisa Cioce MD, PGY-2 March 10, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Esam H. Alhamad, M.D Assistant Professor of Medicine Consultant Pulmonary & Critical Care Medicine.
Mental Status Changes. History 52 y o female presented to the ED with mental status changes Bradycardia noted in ED.
Lung Transplantation Biology
HARVEY®Simulation Exam VCU Internal Medicine M3 Clerkship IMSPE Exam.
History : 52-year-old male presented with a left testicular mass. An initial chest radiograph was performed, followed by a CT. Question : What are the.
R1 정수웅.  Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic, progressive, fibrosing interstitial pneumonia of unknown cause that occurs.
Usual interstitial pneumonia (UIP),
Restrictive lung disease
Interstitial Lung Diseases Pulmonary Medicine Department Ain Shams University
Ganesh Raghu, Harold R. Collard, Jim J. Egan, Fernando J. Martinez, Juergen Behr, Kevin K. Brown et al on behalf of the ATS/ERS/JRS/ALAT Committee on Idiopathic.
Clinical Case 11 th February th Course of Diffuse Parenchymal Lung Diseases.
Figure 1. Proposed mechanisms in the pathogenesis of hypersensitivity pneumonitis. exaggerated immune reaction activation of the fibroblast accumulation.
Clinical Tools for the Primary Care Physician. Objectives Raise the clinical index of suspicion for ILD in patients presenting with the hallmark signs.
Kevin O. Leslie, MD, Mayo Clinic, Scottsdale, Arizona
Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Demystifying Idiopathic Interstitial Pneumonia Arch.
1 COPD (Definitions + Pathology) Dr.Mohsen SHAHEEN Pneumologist Dr.Mohsen SHAHEEN Pneumologist.
IPF Diagnostic Methods and Differential Diagnosis
Smoking related interstitial fibrosis – a new entity
Diseases of the respiratory system lecture 5
Respiratory Disorders
Case of the Month 28 October 2017
UIP or not UIP Pattern: That is not the Only Question
Case studies in OI management
Patient with IPF and no honeycombing on HRCT
To treat or not to treat? IPF and preserved lung function
Idiopathic Pulmonary Fibrosis: Current Concepts
831_ePAT CARE: Patient case Dr. Molina Dr
The Role of Imaging in Diagnosing IPF Hands-On Case Studies
Patient with IPF and concomitant emphysema
Combined pulmonary fibrosis and emphysema (CPFE): an increasingly diagnosed condition Authors: Giovanna Elisiana Carpagnano (Foggia) Ennio Vincenzo.
CASE HISTORY Dr. Zahoor.
Respiratory MCNs - Interstitial lung diseases
Name: Age: Sex: Presenting History Symptom progression Current status:
Trials and the Tyranny of Arbitrary Cut-offs in Idiopathic Pulmonary Fibrosis David thickett 11 July 2014.
Patient with FVC>90% predicted
Pathological alterations in idiopathic pulmonary fibrosis (IPF).
Changes in high-resolution computed tomography (HRCT) pattern over time. a) Idiopathic pulmonary fibrosis (IPF), increased specificity over time. Changes.
Usual Interstitial Pneumonia Complicating Dyskeratosis Congenita
Interstitial lung disease
Pulmonary 1, Case 6 56-year-old man with progressive dyspnea and bilateral infiltrates in lung.
How is pulmonary fibrosis diagnosed and monitored?
832_epat care: PATIENT CASE dr. aguilaniu dr
Evaluation of acute symptoms
Volume 155, Issue 3, Pages e69-e74 (March 2019)
Transbronchial cryobiopsy (TBCx)
Hypersensitivity pneumonia: UIP/IPF histopathologic presentation
Medical case history 80-year-old man, current smoker (60 p/y)
Diagnostic algorithm for idiopathic pulmonary fibrosis (IPF).
Presentation transcript:

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ Clinical Case

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ Female Caucasian 57 years old Retired (former teacher) Living in Braga (urban centre) Married Ex-smoker (<10 cig/day for 30 years) Medication: alprazolam 0.25mg, ocasionally Without known occupational or professional exposure Personal history unremarkable Mother with history of “pulmonary fibrosis”

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ February 2011 – 1st consult Major complaint of “dry”, persistent cough in the last 6 months Mild intermittent hand joint pain in the last 2 years Physical examination: Good performance status Weight: 74Kg Lung auscultation: velcro-like crackles in basal areas Skin and joints without significant changes

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ Lung HRCT – February 2011

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ Lung HRCT – February 2011

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ Lung HRCT – February 2011

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ Lung HRCT – February 2011

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ Lung HRCT – February 2011

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ Laboratory analysis: unremarkable except ANA 1/80. BAL fluid: Total cellular count: 247 cel/uL Differential count: lymphocytes 31% (CD4/CD8=2.0), neutrophils 13%, eosinophils 8%, macrophages 48% Evaluation from Rheumatology and Internal Medicine/Autoimmune diseases – no evidence of systemic/inflammatory disease

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ Lung function (2011)

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ 6-minute walking test: 97>90%; 545m. Rest EKG and echocardiogram both normal.

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ March 2011 Case presented at interstitial lung disease multidisciplinary group in HSJ: Probable usual interstitial pneumonia Questions raised: IPF? Sub-clinical systemic disease related? Chronic hypersensitivity pneumonitis?

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ April 2011 – Surgical Lung Biopsy

Subpleural and paraseptal predominance Patchy parenchyma involvement

Subpleural and paraseptal predominance Patchy parenchyma involvement

Established fibrosis leading to loss of architecture (honeycombing)

Fibroblastic foci adjacent to the established fibrosis

Diagnosis: Usual interstitial pneumonia (UIP) Reactive smooth-muscle hyperplasia Subpleural fatty metaplasia Dilated lymphatics Distorted air spaces Hyperplastic bronchiolar epithelium Thickened blood vessel walls

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ Definite (?) diagnosis: IPF Treatment options discussed with the patient Initiated deflazacort + azathioprine + N-acetylcysteine in June 2011. Transplant centre referral

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ Evolution (2011-2014) Mild exertional dyspnea and chronic cough; stable until the last 3 months with slight deterioration Current treatment: deflazacort 6mg + azatioprine 150mg + N-acetylcysteine 1800mg /day Respiratory rehabilitation program Relevant events: Flu (2012) Herpes-zoster infection (2013)

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ Evolution (2011-2014) Lung Function 2011 2012 2013 FVC (%) 102 101 92 FEV1 (%) 103 93.5 FEV1/FVC 85 84 TLC (%) 88 83 DLCO (%) 64 51 42 DLCO/VA (%) 75 68 47 6MWT (satO2) 97>90% 96>91% 98>90% 6MWT (dist) 545m 540m 500m

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ Evolution (2011-2014) HRCT – 2011 HRCT – 2014

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ Evolution (2011-2014) HRCT – 2011 HRCT – 2014

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ Evolution (2011-2014) HRCT – 2011 HRCT – 2014

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ Evolution (2011-2014) HRCT – 2011 HRCT – 2014

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ Evolution (2011-2014) HRCT – 2011 HRCT – 2014

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ Evolution (2011-2014) Echocardiogram (2013): abnormal left ventricular relaxation; mild tricuspid insufficiency (estimated pulmonary artery systolic pressure – 47 mmHg). Paranasal sinus CT scan: chronic rinitis Osteodensitometry: within normal range Abdominal echography: hepatic cyst

3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ Evolution (2011-2014) Female patient, 60 years old, with chronic dry cough and exertional dyspnea since 2011, experiencing recent slight deterioration. Radiologic and pathologic UIP-pattern disease IPF with slowly progressive disease? Should we change pharmacological treatment?